Cargando…
Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection
OBJECTIVE: This study aimed to describe treatment of serious complications after primary thoracic endovascular aortic repair (TEVAR) in type B aortic dissection. METHODS: From June 2008 to March 2016, serious complications occurred in 58 patients without Marfan syndrome who received TEVAR for type B...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718725/ https://www.ncbi.nlm.nih.gov/pubmed/28701057 http://dx.doi.org/10.1177/0300060517708893 |
_version_ | 1783284370839175168 |
---|---|
author | Liu, Zhao Zhang, Yepeng Liu, Chen Huang, Dian Zhang, Ming Ran, Feng Wang, Wei Shang, Tao Qiao, Tong Zhou, Min Liu, Changjian |
author_facet | Liu, Zhao Zhang, Yepeng Liu, Chen Huang, Dian Zhang, Ming Ran, Feng Wang, Wei Shang, Tao Qiao, Tong Zhou, Min Liu, Changjian |
author_sort | Liu, Zhao |
collection | PubMed |
description | OBJECTIVE: This study aimed to describe treatment of serious complications after primary thoracic endovascular aortic repair (TEVAR) in type B aortic dissection. METHODS: From June 2008 to March 2016, serious complications occurred in 58 patients without Marfan syndrome who received TEVAR for type B aortic dissection. RESULTS: Complications included endoleak, distal true lumen collapse, retrograde dissection, stroke, stent–graft (SG) migration and mistaken deployment, lower limb ischaemia, and SG fracture. Treatment included endovascular repair, surgical procedures, or conservative medication. Forty-six patients recovered from complications. Twelve patients were not cured. The median follow-up time was 29.5 months (2–61 months). The overall 30-day mortality rate was 1.7% (1/58) and the total mortality rate following secondary complications was 8.6% (5/58). The causes of death were stroke and aortic rupture. CONCLUSION: Some treatments need to be performed after TEVAR because of severe complications. A reduction in these complications can be achieved by optimal evaluation of patients, selection of SGs, and specialized endovascular manipulation. |
format | Online Article Text |
id | pubmed-5718725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-57187252017-12-11 Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection Liu, Zhao Zhang, Yepeng Liu, Chen Huang, Dian Zhang, Ming Ran, Feng Wang, Wei Shang, Tao Qiao, Tong Zhou, Min Liu, Changjian J Int Med Res Clinical Reports OBJECTIVE: This study aimed to describe treatment of serious complications after primary thoracic endovascular aortic repair (TEVAR) in type B aortic dissection. METHODS: From June 2008 to March 2016, serious complications occurred in 58 patients without Marfan syndrome who received TEVAR for type B aortic dissection. RESULTS: Complications included endoleak, distal true lumen collapse, retrograde dissection, stroke, stent–graft (SG) migration and mistaken deployment, lower limb ischaemia, and SG fracture. Treatment included endovascular repair, surgical procedures, or conservative medication. Forty-six patients recovered from complications. Twelve patients were not cured. The median follow-up time was 29.5 months (2–61 months). The overall 30-day mortality rate was 1.7% (1/58) and the total mortality rate following secondary complications was 8.6% (5/58). The causes of death were stroke and aortic rupture. CONCLUSION: Some treatments need to be performed after TEVAR because of severe complications. A reduction in these complications can be achieved by optimal evaluation of patients, selection of SGs, and specialized endovascular manipulation. SAGE Publications 2017-07-12 2017-10 /pmc/articles/PMC5718725/ /pubmed/28701057 http://dx.doi.org/10.1177/0300060517708893 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Clinical Reports Liu, Zhao Zhang, Yepeng Liu, Chen Huang, Dian Zhang, Ming Ran, Feng Wang, Wei Shang, Tao Qiao, Tong Zhou, Min Liu, Changjian Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection |
title | Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection |
title_full | Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection |
title_fullStr | Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection |
title_full_unstemmed | Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection |
title_short | Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection |
title_sort | treatment of serious complications following endovascular aortic repair for type b thoracic aortic dissection |
topic | Clinical Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718725/ https://www.ncbi.nlm.nih.gov/pubmed/28701057 http://dx.doi.org/10.1177/0300060517708893 |
work_keys_str_mv | AT liuzhao treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection AT zhangyepeng treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection AT liuchen treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection AT huangdian treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection AT zhangming treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection AT ranfeng treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection AT wangwei treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection AT shangtao treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection AT qiaotong treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection AT zhoumin treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection AT liuchangjian treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection |